Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

3 Beer Stocks: What This Analyst Thinks Is Brewing

Published 22/03/2024, 15:33
Updated 22/03/2024, 16:40
© Reuters.  3 Beer Stocks: What This Analyst Thinks Is Brewing

Benzinga - by Priya Nigam, Benzinga Staff Writer.

With consumer spending taking a hit on elevated interest rates, more economical alcohol brands, especially beer stocks, have been in focus.

Analyst Michael Lavery of Piper Sandler initiated coverage of these three beer brands, highlighting their prospects.

The Ratings:

  • Molson Coors Beverage Co (NYSE: TAP): Neutral, with a price target of $69.
  • Boston Beer Company Inc (NYSE: SAM): Overweight, with a price target of $350.
  • Constellation Brands, Inc. (NYSE: STZ): Overweight, with a price target of $300.

The Molson Coors Beverage Thesis: The company gained market share in 2023 at the expense of Anheuser-Busch Inbev SA's (NYSE: BUD) Bud Light and “we expect an outsized share lift for it through April 2024,” Lavery said in the initiation note.

“We expect TAP to benefit from mix lifts from premiumization of its portfolio, but upside beyond beer looks smaller,” the analyst wrote. “Margin expansion looks achievable to us, but its ongoing strike adds near-term disruption costs and some uncertainty,” he added.

The Boston Beer Company Thesis: Twisted Tea and Hard Dew are expected to drive top-line growth, while Hard Mtn Dew could lend “significant upside vs. our estimates (and consensus), based on its initial traction in limited distribution,” Lavery said.

“Smaller launches like Truly Unruly and Sun Cruiser can add to growth, too,” the analyst stated. He expressed optimism around continued gross margin expansion driving robust earnings growth.

The Constellation Brands Thesis: The company is poised to benefit from “long-term, sustainable U.S. market share tailwinds, as Mexican imports, and its strong brands in particular, have been gaining share for many years,” Lavery wrote in the note.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Constellation Brands invested around $550 million in R&D over the last five years and its “innovation tailwinds” could continue, the analyst said.

“STZ is targeting 33-35% enterprise operating margins (F23: ~32%) for F25-F28, and we consider this achievable, with likely upside potential, though commodity input cost variations and other factors are medium-term unknowns,” he added.

TAM, SAM, STZ Price Action: Molson Coors Beverage shares were up 0.21% at $67.23, Boston Beer Company shares were up 1.32% at $298.47 and Constellation Brands were down 0.60% to $267.73 at the time of publication on Friday.

Photo: Shutterstock

Latest Ratings for TAP

Feb 2022Morgan StanleyMaintainsEqual-Weight
Feb 2022CitigroupMaintainsBuy
Nov 2021BarclaysMaintainsEqual-Weight

View the Latest Analyst Ratings

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.